Search

0207 901 8500 We Are Open
Get in touch

Mr. Will Sarakbi

Mr Will Sarakbi LMSSA (Lond) LRCP (Lond) LRCS (Eng) MS (University of London) FRCS (Eng) is a Consultant Oncoplastic Breast Surgeon at Croydon University Hospital and an Honorary Consultant Surgeon at St.Georges Hospital. He qualified from St George’s, the University of London in 2001. After completing his basic surgical training in the South East of England, he spent some time in full-time research focusing on breast cancer biology and examining the role of molecular markers, such STS and OATP as prognostic indicators in breast cancer. He was awarded a Masters degree in surgery from the University of London. 

His research work has generated over 22 papers in peer-reviewed journals and he has presented his findings in national and international conferences in the UK, Europe and the USA. He is also a member of the Intensity-Modulated Partial Organ Radiotherapy Trial (IMPORT) trial management group, one of the largest currently running radiotherapy trials in the UK funded by Cancer Research UK, investigating new techniques of delivering radiotherapy in breast cancer. 

Following his research, Mr Sarakbi continued his higher surgical training in the London Deanery, spending almost two years at Guys and St Thomas’ Hospital. Mr Sarakbi was elected to the post of President of the National Breast Trainees Association (The Mammary Fold) (2010) and subsequently to the post of President of the Surgical Oncology Trainees Association (SOTA) (2012). He was selected for the prestigious national Aesthetic and Reconstructive Fellowship, which provided him with world-class training in both cosmetic and reconstructive breast surgery. 

He also spent time training in France at the Leon-Bérard Centre in Lyon, working with internationally renowned reconstructive surgeons, where he mastered advanced techniques in breast reconstruction and cosmetic breast surgery, including lipomodelling (fat transfer). Mr Sarakbi has also completed over 25 national and international courses to further develop his skills in both reconstructive and aesthetic breast surgery. 

Mr Sarakbi has been practicing aesthetic breast surgery as a consultant for over 8 years. He has performed over 800 breast augmentations, 250 breast reduction procedures, and 200 breast uplift surgeries. He has a wealth of experience in the field of breast surgery, particularly that he also performs breast cancer surgery and breast reconstruction both in the NHS and the private sector. He has a large number of reviews on Doctify.com and iwantgreatcare.org

Mr. Will Sarakbi

World Class Results

Please select a treatment to view the results gallery.

Breast Augmentation Breast Lift Breast Reduction

C Kirwan, W Al Sarakbi, HY Chan, AM Thompson, GC Wishart. “Tumour bed localisation for targeted breast radiotherapy: Compliance is proportional to trial-related research activity: Tumour bed clip localisation in breast radiotherapy. ” Eur J Surg Oncol 2014 Feb;40(2):158-62. ( on the behalf of the IMRORT trialists group) LINK: http://www.ncbi.nlm.nih.gov/pubmed/24373297

Wazir U, Al Sarakbi W, Jiang W, Mokbel K. Evidence of an autocrine role for leptin and leptin receptor in human breast cancer. Cancer Genomics Proteomics. 2012 Nov;9(6):383-7. LINK: http://www.ncbi.nlm.nih.gov/pubmed/23162077

Al Sarakbi W, Bentley PG. Whole gut intubation splinting – Last refuge for the surgically desperate? Annals of The Royal College of Surgeons . 529-530(2) Sep 2010 LINK: http://www.ncbi.nlm.nih.gov/pubmed/20819334

Al Sarakbi W, Reefy S, Jiang W G, Roberts T, Newbold RF, Mokbel K Evidence of a Tumour Suppressor Function for DLEC1 in Human Breast Cancer. Anticancer Research 2010 Jun;30(6):2481. LINK: http://www.ncbi.nlm.nih.gov/pubmed/20530412

W Al Sarakbi, W Sasi, W G Jiang, T Roberts, R F Newbold and K Mokbel. The mRNA expression of SETD2 in human breast cancer: correlation with clinic-pathological parameters. BMC Cancer 2009 Aug 21;9:290. LINK: http://www.ncbi.nlm.nih.gov/pubmed/19698110

Tullie L, Charkaoui L, Al Sarakbi W, Sever A. Breast augmentation with Collagen injections. BMJ Case Reports. Doi:10.1136/bcr.06.2011.4387. LINK: http://www.ncbi.nlm.nih.gov/pubmed/22679230

Li KS, Khwaja HA, Hayat TT, Asghar A, Alsarakbi W, Kelley C, Babu ED. A rare cause of abdominal pain. Ann R Coll Surg Engl. 2007 Jul;89(5):W14-6. LINK: http://www.ncbi.nlm.nih.gov/pubmed/?term=ALSARAKBI

Al Sarakbi W, Reed M J, Salhab M, Jiang W G, Mokbel K. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Research 2006 Nov-Dec;26(6C):4985-90. http://www.ncbi.nlm.nih.gov/pubmed/17214375 

Al Sarakbi W, YM Chong, SLJ Williams, AK Sharma, K Mokbel. The mRNA expression of IGF-1 and IGF-1R in human breast cancer: correlation with clinico-pathological parameters. Journal of Carcinogenesis. 2006, 5:16. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16725048

Al Sarakbi W, Salhab M, Mokbel K. Does mammary ductoscopy have a role in clinical practice? Int Semin Surg Oncol. 2006 Jun 30;3(1):16. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16808852

Al Sarakbi W, Salhab M, Thomas V, Mokbel K. Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? Int Semin Surg Oncol. 2005 Aug 22;2:15. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16115314

Al Sarakbi W, Salhab M, Mokbel K. Dairy products and breast cancer risk: a review of the literature. Int J Fertil Womens med 2005 Nov-Dec;50(6):244-9. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16526414 

Al Sarakbi W, Agrawal A, Taffinder N. A giant inguinoscrotal hernia: a case report and review of the literature. Grand Round. 2005 Nov; Vol (5): 46-48. 

Al Sarakbi W, Worku D, Escobar PF, Mokbel K. Breast papillomas: Current management with a focus on a new diagnostic and therapeutic modality. Int Semin Surg Oncol. 2006 Jan 17;3:1. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16417642

Salhab M, Al Sarakbi W, Joseph A, Sheards S, Travers J, Mokbel K. Skin-sparing mastectomy and immediate breast reconstruction: patient satisfaction and clinical outcome. Int J Clin Oncol. 2006 Feb;11(1):51-4. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16508729

Salhab M, Al Sarakbi W, Perry N, Mokbel K. Pneumothorax after a clinical breast fine-needle aspiration of a lump in a patient with Poland's syndrome. Int Semin Surg Oncol. 2005 Aug 19;2:14. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16111483

Salhab M, Al Sarakbi W, Mokbel K. Breast weight and hormone receptor status in women with breast cancer. Int Semin Surg Oncol. 2005 May 16;2(1):11. LINK: http://www.ncbi.nlm.nih.gov/pubmed/15904529

Elkak A, Al Sarakbi W, Mokbel K. SYK expression in human breast cancer. J Carcinogenesis. 2005 Apr 20;4(1):7. LINK: http://www.ncbi.nlm.nih.gov/pubmed/15842733

Salhab M, Al Sarakbi W, Mokbel K. The evolving role of the dynamic thermal analysis in the early detection of breast cancer. Int Semin Surg Oncol. 2005 Apr 8;2(1):8. LINK: http://www.ncbi.nlm.nih.gov/pubmed/15819982

Mokbel K, Lirosi F, Al-Sarakbi W, Leris C. Women's views on the introduction of Annual Screening Mammography to those aged 40-49 years (Pilot study). Curr Med Res Opin. 2001;17(2):111-2. LINK: http://www.ncbi.nlm.nih.gov/pubmed/11759178

Salhab M, Al Sarakbi W, Mokbel K. Skin and fat necrosis of the breast following methylene blue dye injection in a patient with breast cancer. Int Semin Surg Oncol. 2005 Nov 28;2(1):26. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16313674

Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K. The role of aromatase and 17-I(2)-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Breast Cancer Res Treat. 2006 Sep;99(2):155-62 LINK: http://www.ncbi.nlm.nih.gov/pubmed/16541304

Salhab M, Al Sarakbi W, Mokbel K. In vitro fertilization and breast cancer risk: a review. Int J Fertil Womens Med. 2005 Nov-Dec;50(6):259-66. Review. LINK: http://www.ncbi.nlm.nih.gov/pubmed/16526416 

Al Sarakbi W, Escobar P, Mokbel K. The potential role of mammary ductoscopy in early detection of breast cancer. Int J Fertil Womens med. 2005 November; Vol 50, (5).

 

Testimonials

Find out more

If you have any questions or queries please call to speak to one of our advisors or request a call back to speak at a time that suits you.

0207 901 8500 Request a Callback

Other Specialists

In The Media

This month Consultant Dermatologist Dr Susan Mayou discusses rosacea with Heart.co.uk, and talks to the Daily Mail about the latest skincare craze, chlorophyll.

Read more

News publications Cadogan Clinic features in
CQC BAAPS BAPRAS British Skin Foundation British Association of Dermatology ALLERGAN official partner